Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial

Detalles Bibliográficos
Autores principales: Leung, Christopher Kai Shun, Ren, Seraph Tianmin, Chan, Poemen Pui Man, Wan, Kelvin Ho Nam, Kam, Aziz Ka Wai, Lai, Gilda Wing Ki, Chiu, Vivian Sheung Man, Ko, Match Wai Lun, Yiu, Cedric Ka Fai, Yu, Marco Chak Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832638/
https://www.ncbi.nlm.nih.gov/pubmed/35144657
http://dx.doi.org/10.1186/s13063-022-06079-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832638/
https://www.ncbi.nlm.nih.gov/pubmed/35144657
http://dx.doi.org/10.1186/s13063-022-06079-1

Ejemplares similares